OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
14.24
-0.41 (-2.80%)
Dec 5, 2025, 4:00 PM EST - Market closed
OptimizeRx Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for OptimizeRx stock have an average target of 14.83, with a low estimate of 6.00 and a high estimate of 24. The average target predicts an increase of 4.14% from the current stock price of 14.24.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for OptimizeRx stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Hold Maintains $20 → $17 | Hold | Maintains | $20 → $17 | +19.38% | Nov 17, 2025 |
| Citizens | Citizens | Buy Maintains $23 → $24 | Buy | Maintains | $23 → $24 | +68.54% | Nov 7, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $20 → $23 | Buy | Maintains | $20 → $23 | +61.52% | Oct 10, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $14 → $20 | Buy | Maintains | $14 → $20 | +40.45% | Aug 11, 2025 |
| Stifel | Stifel | Strong Buy Maintains $16 → $18 | Strong Buy | Maintains | $16 → $18 | +26.40% | Aug 8, 2025 |
Financial Forecast
Revenue This Year
110.34M
from 92.13M
Increased by 19.77%
Revenue Next Year
122.84M
from 110.34M
Increased by 11.33%
EPS This Year
0.76
from -1.10
EPS Next Year
0.90
from 0.76
Increased by 17.37%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 116.3M | 133.7M | |
| Avg | 110.3M | 122.8M | |
| Low | 104.6M | 110.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 26.3% | 21.2% | |
| Avg | 19.8% | 11.3% | |
| Low | 13.5% | 0.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.81 | 1.08 | |
| Avg | 0.76 | 0.90 | |
| Low | 0.70 | 0.71 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 41.7% | |
| Avg | - | 17.4% | |
| Low | - | -7.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.